new
coronaviru
discov
due
detect
unfamiliar
pneumonia
group
patient
decemb
wuhan
china
initi
name
novel
coronaviru
world
health
organ
januari
research
sequenc
genom
new
viru
figur
genom
sarscov
genom
afterward
name
chang
sever
acut
respiratori
syndrom
corona
accord
coronaviru
diseas
situat
report
data
report
cet
march
case
global
confirm
person
die
intern
committe
taxonomi
virus
ictv
recent
classifi
uniqu
speci
genera
alphacov
betacov
gammacov
deltacov
mammal
infect
alpha
beta
wherea
gammacov
deltacov
abl
afflict
bird
also
human
corona
virus
respons
respiratori
complic
human
discov
far
hcov
new
corona
viru
recent
spread
worldwid
consid
betacov
genu
outbreak
sever
acut
respiratori
syndrom
sar
coronavirus
nt
regard
highli
pathogen
human
phenotyp
method
like
cultur
electron
microscopi
serolog
studi
employ
recogn
viru
coronavirus
identifi
pleomorph
envelop
virus
contain
crownshap
peplom
nm
size
kb
posit
polar
result
mani
research
carri
structur
coronaviru
genom
properli
known
four
structur
protein
spike
envelop
e
membran
nucleocapsid
n
protein
besid
helper
protein
account
onethird
genom
twothird
encod
viral
polymeras
rdrp
rna
synthesi
materi
two
type
huge
nonstructur
protein
protein
surfac
viru
shape
viru
crown
protein
function
make
interact
sensit
cell
viru
genom
enter
cell
cytoplasm
genom
rna
encod
variou
structur
nonstructur
polypeptid
gene
shape
viru
reform
along
alter
sproteincod
gene
e
type
function
small
transmembran
protein
nucleocapsid
n
use
clone
gener
recombin
protein
cov
extrem
recombin
outcom
repetit
develop
transcript
error
rna
depend
rna
polymeras
rdrp
jump
sourc
infect
origin
case
relat
seafood
wholesal
market
sinc
similar
batcov
gene
detect
bat
research
suppos
bat
initi
host
follow
studi
suggest
pig
pangolin
possibl
intermedi
host
anim
repositori
probabl
snake
appear
infect
first
transmit
zoonot
agent
anim
human
despit
sea
food
market
close
rate
infect
patient
increas
indic
humantohuman
transmiss
respiratori
droplet
relat
human
respiratori
activ
talk
cough
sneez
direct
contact
probabl
transmiss
rout
case
show
way
transmiss
like
fecalor
transmiss
fomit
transmiss
transfer
viru
via
object
perinat
intrauterin
transmiss
research
neg
rout
investig
research
believ
limit
sampl
affect
neg
result
reliabl
studi
conduct
surviv
coronavirus
food
indic
foodborn
transmiss
microbicid
effect
coronavirus
exampl
alcohol
aldehyd
phenol
essenti
awar
clinic
manifest
even
though
symptom
nonspecif
common
symptom
fever
nonproduct
cough
myalgia
fatigu
normal
decreas
leukocyt
count
radiograph
evid
pneumonia
first
peopl
may
complain
diarrhea
nausea
day
later
develop
fever
fever
usual
detect
patient
main
symptom
headach
dizzi
abdomin
pain
diarrhea
nausea
vomit
less
common
symptom
icu
care
requir
age
patient
patient
like
comorbid
includ
hypertens
diabet
cardiovascular
diseas
cerebrovascular
disord
subsequ
problem
hospit
mostli
acut
respiratori
syndrom
ard
arrhythmia
shock
accord
scientif
observ
statu
patient
get
wors
urea
creatinin
blood
level
gradual
rise
anoth
common
symptom
patient
lymphopenia
possibl
seriou
issu
hospit
may
correl
lymphopenia
sever
mortal
diseas
diagnos
base
ask
question
contact
travel
patient
past
two
week
accur
test
like
molecular
method
serolog
viral
cultur
rtpcr
real
time
polymeras
chain
reaction
molecular
method
commonli
use
diagnosi
lower
respiratori
tract
sampl
better
upper
one
higher
viral
load
method
defect
antibodi
detect
less
sensit
viral
cultur
take
time
nation
health
health
commiss
china
recommend
comput
tomographi
scan
ct
scan
main
way
diagnosi
rtpcr
may
error
sampl
radiolog
test
import
earli
detect
diseas
chest
ct
imag
patient
broadspectrum
regular
chest
ct
result
bilater
distribut
patchi
shadow
ground
glass
opac
ggo
establish
help
antivir
agent
urgent
need
number
drug
claim
safe
effici
random
control
trial
howev
two
allow
fda
far
chloroquin
sulfat
hydroxychloroquin
sulfat
follow
overview
drug
use
undergo
trial
present
conduct
numer
test
determin
efficaci
chloroquin
sulfat
cq
hydroxychloroquin
sulfat
hcq
current
use
firstlin
treatment
drug
countri
chloroquin
old
drug
use
malaria
inexpens
safe
elder
patient
accord
studi
compar
cq
hcq
fewer
side
effect
longterm
use
fewer
drugdrug
interact
use
higher
dose
possibl
combin
hydroxychloroquin
azithromycin
may
posit
effect
especi
sever
case
despit
efficaci
two
drug
recoveri
process
may
side
effect
includ
gastrointestin
respons
risk
cardiac
arrhythmia
risk
retin
damag
especi
long
term
use
remdesivir
new
antivir
agent
examin
inhibit
viral
replic
prematur
termin
rna
transcript
capabl
affect
wide
rang
rna
virus
sever
clinic
trial
indic
effici
remdesivir
treatment
procedur
antivir
agent
inhibit
proteas
activ
coronaviru
hiv
vitro
anim
model
studi
lopinavir
lpv
ribavirin
guanosin
analogu
differ
observ
viral
shed
treatment
kaletra
combin
drug
lopinavir
ritonavir
european
societi
intens
care
medicin
esicm
nt
recommend
routin
use
kaletra
corticosteroid
inhibit
immun
respons
pathogen
clearanc
spite
suppress
lung
inflamm
evidencebas
reason
consid
corticosteroid
help
treatment
process
rather
like
harm
interim
guidanc
clinic
manag
sever
acut
respiratori
infect
releas
march
suggest
use
corticosteroid
infect
suspect
except
except
circumst
especi
sever
case
prescrib
care
drug
still
investig
antiinfluenza
drug
umifenovir
oseltamivir
use
treatment
sar
mer
beta
coronavirus
spread
two
decad
ago
research
make
great
effort
find
effici
drug
use
random
control
trial
necessari
util
worldwid
spread
becom
critic
health
issu
nevertheless
knowledg
yet
acquir
public
health
effort
need
restrict
outbreak
viru
via
human
human
transfer
seem
best
approach
current
situat
